U.S. market Closed. Opens in 13 hours 46 minutes

ADMA | ADMA Biologics, Inc. Stock Fundamentals

(Stock Exchange: NASDAQ)
Analyzing fundamentals for ADMA we got that it has average fundamentals where Valuation is considered to be overvalued, Profitability is moderate, Growth is good and Health is strong.

Valuation (38%)

Company Industry
P/E Ratio (TTM) 60.08 N/A
PEG Ratio (TTM) 0.64 N/A
P/S Ratio (TTM) 10.78 N/A
P/B Ratio (TTM) 17.65 N/A
P/FCF Ratio (TTM) 52.10 N/A
Price to 5YR AVG Earnings Ratio -27.03 N/A
Price to 5YR AVG FCF Ratio -52.86 N/A

Profitability (60%)

Company Industry
ROA (TTM) 17.44% N/A
ROE (TTM) 38.44% N/A
Net Profit Margin (TTM) 17.80% N/A
ROIC 5YR AVG -21.41% N/A

Growth (63%)

4QTR AVG 3YR AVG 5YR AVG
EPS -124.60% 23.55% 33.98%
Revenue 15.84% 69.45% 73.26%
Net Income -123.73% -12.25% 5.85%
Cash Flow 511.76% -21.87% 19.25%

Health (67%)

Company Industry
Current Ratio (TTM) 7.09 N/A
Quick Ratio (TTM) 3.26 N/A
D/E Ratio (TTM) 0.44 N/A
Interest Coverage (TTM) 6.65 N/A
Piotroski F-Score 5 N/A
Altman Z-Score 16.67 N/A
LTL to 5YR AVG FCF -1.80 N/A
Shares Outstanding Growth 5YR AVG 39.15% N/A
An error has occurred. This application may no longer respond until reloaded. Reload 🗙